Skip to content

Pancreatitis of biliary origin: Optimal timiNg CHOlecystectomy (PONCHO) trial

Pancreatitis of biliary origin: Optimal timiNg CHOlecystectomy (PONCHO) trial. A randomised controlled multicentre trial of the Dutch Pancreatitis Study Group.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72764151
Enrollment
265
Registered
2010-06-29
Start date
2011-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild biliary pancreatitis Digestive System Acute pancreatitis

Interventions

1. Intervention group: Laparoscopic cholecystectomy within 72 hours after randomisation (ELC). 2. Control group: Laparoscopic cholecystectomy 25-30 days after randomization (ILC). Patients are ran

Sponsors

Radboud University Nijmegen Medical Centre (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 24/04/2012 1. Age 18 years or older 2. Mild (non-severe) biliary pancreatitis; no pancreatic necrosis and/or peripancreatic collections and no persistent (>48hr) organ failure 3. First episode of acute pancreatitis 4. Written and oral informed consent (obtained prior to randomisation) Previous inclusion criteria 1. Age 18 years or older 2. Mild (non-severe) biliary pancreatitis, without sterile pancreatic necrosis and/or peripancreatic collections. 3. Written and oral informed consent (obtained prior to randomisation)

Exclusion criteria

Exclusion criteria: Curent exclusion criteria as of 24/04/2012 1. Patients 75 years with ASA III 3. ASA IV and V patients 4. Patients with ongoing alcohol abuse or chronic pancreatitis 5. Pregnancy Previous exclusion criteria 1. Patients 75 years with ASA III 3. ASA IV and V patients 4. Patients with history of alcohol abuse or chronic pancreatitis 5. Mild pancreatitis with sterile pancreatic necrosis and/or peripancreatic collections 6. Severe pancreatitis: persistent (>48hrs) organ failure or necrotizing pancreatitis

Design outcomes

Primary

MeasureTime frame
Current primary outcome as of 24/04/2012 Composite endpoint: Unplanned re-admission for biliary events (recurrent biliary pancreatitis, acute cholecystitis, choledocholithiasis mandating ERCP, biliary colics) and mortality Previous primary outcome Composite endpoint: Unplanned re-admission for biliary events (recurrent biliary pancreatitis, acute cholecystitis, choledocholithiasis mandating ERCP, biliary colics)

Secondary

MeasureTime frame
1. Individual components of the primary endpoint 2. Number of biliary colics after randomisation 3. Length of hospital stay 4. Operation difficulty (VAS) 5. Duration 6. Complications and conversion rate of laparoscopic cholecystectomy 7. Costs per primary endpoint avoided 8. Quality adjusted life year (QALY) gained 9. Mortality 10. Patient satisfaction

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026